Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Article in The Journal of Headache and Pain (February 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in The Journal of Headache and Pain (February 2024)
Book chapter (January 2024)
Book chapter (January 2024)